We represented Epredia as it invests in AI-company Aiforia
Transactions and Finance
29.6.2021
.jpg)
Team
Services
We represented Epredia as it invests in AI-company Aiforia
Epredia invests in Aiforia, a software company providing AI-based solutions for clinical and preclinical image analysis in pathology. The size of the Series B financing round is €12.6M with the potential to reach €25.2M if investors exercise the optional second tranche.
Epredia is a global leader in the anatomical pathology field, providing comprehensive solutions for precision cancer diagnostics and tissue diagnostics. The funding round is led by Epredia’s UK entity, a subsidiary of PHC Holdings Corporation.
Read more on Aiforia´s website.
Further information
.jpg)
.jpg)
Subscribe to our newsletter
We regularly write on current topics related to our areas of expertise. By entering your email in the form below, you will receive Merilampi's newsletters and event invitations directly to your email.